Compass Therapeutics (CMPX) Current Assets (2018 - 2026)
Compass Therapeutics recorded quarterly Current Assets of $195.7 million in Q1 2026, down 6.74% quarter-over-quarter from $209.8 million in Q4 2025, and up 57.63% year-over-year from $124.1 million in Q1 2025.
Compass Therapeutics' Current Assets history runs 9 years deep, the most recent figure standing at $195.7 million for Q1 2026.
- In Q1 2026, Current Assets rose 57.63% year-over-year to $195.7 million; the TTM figure through Mar 2026 stood at $195.7 million (up 57.63% YoY), while the FY2025 annual figure was $209.8 million, up 58.05% from the prior year.
- Current Assets came in at $195.7 million for Q1 2026 at Compass Therapeutics, down from $209.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $221.1 million in Q3 2025 to a low of $106.2 million in Q2 2025.
- A 5-year average of $159.7 million and a median of $153.9 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 328.93% in 2022 and plunged 30.84% in 2025, its largest moves.
- Compass Therapeutics' Current Assets stood at $194.8 million in 2022, then fell by 21.0% to $153.9 million in 2023, then slipped by 13.73% to $132.8 million in 2024, then surged by 58.05% to $209.8 million in 2025, then dropped by 6.74% to $195.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $195.7 million, $209.8 million, and $221.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | 195.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.69 Mn |
| Dec 31, 2025 | 209.82 Mn |
| Sep 30, 2025 | 221.12 Mn |
| Jun 30, 2025 | 106.20 Mn |
| Mar 31, 2025 | 124.15 Mn |
| Dec 31, 2024 | 132.75 Mn |
| Sep 30, 2024 | 141.14 Mn |
| Jun 30, 2024 | 153.55 Mn |
| Mar 31, 2024 | 158.61 Mn |
| Dec 31, 2023 | 153.88 Mn |
| Sep 30, 2023 | 166.58 Mn |
| Jun 30, 2023 | 175.27 Mn |
| Mar 31, 2023 | 183.60 Mn |
| Dec 31, 2022 | 194.79 Mn |
| Sep 30, 2022 | 122.55 Mn |
| Jun 30, 2022 | 134.55 Mn |
| Mar 31, 2022 | 140.28 Mn |
| Dec 31, 2021 | 147.11 Mn |
| Sep 30, 2021 | 28.57 Mn |
| Mar 31, 2021 | 41.65 Mn |
| Dec 31, 2020 | 50.20 Mn |
| Sep 30, 2020 | 57.83 Mn |
| Jun 30, 2020 | 67.29 Mn |
| Mar 31, 2020 | 3,745.00 |
| Dec 31, 2019 | 26.24 Mn |
| Sep 30, 2019 | 882.00 |
| Jun 30, 2019 | 4,866.00 |
| Mar 31, 2019 | 4,866.00 |
| Dec 31, 2018 | 4,679.00 |
| Sep 30, 2018 | 2,446.00 |
| Jun 30, 2018 | 7,231.00 |
| Mar 31, 2018 | 25.00 |